Brigham and Women's Hospital: Venous Thrombosis trials

The registry lists 13 Venous Thrombosis studies with Brigham and Women's Hospital as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 4 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous ThromboembolismCompletedNCT04168203Phase 4Results posted
• Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary EmbolismCompletedNCT00413374Not applicableResults posted
• Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic InformationCompletedNCT00401414Not applicableResults posted
• Emulation of the RECORD3 Trial Using Healthcare Claims DataCompletedNCT07599384
• Replication of the RECORD1 Anticoagulant Trial in Healthcare Claims DataCompletedNCT05083455
• Improving Safety of Diagnosis and Therapy in the Inpatient SettingCompletedNCT04393909Not applicable
• The DARE Warfarin CER StudyStatus unknownNCT03271450
• Discharge ALERT: Quality Improvement InitiativeCompletedNCT00853463Not applicable
• 3 Screen Electronic AlertCompletedNCT00550082
• Registry of Hospitalized Patients Treated With FondaparinuxCompletedNCT00549705
• Epidemiology of Venous ThromboembolismCompletedNCT00456196
• Fondaparinux as Monotherapy for DVT and/or Pulmonary EmbolismCompletedNCT00413504Not applicable
• Multi-Center Human Alert Trial to Prevent DVT and PECompletedNCT00409136